Maastricht University Medical Center Clinical Trials
Sponsors / Maastricht University Medical Center
672 ClinicalTrials.gov entries name Maastricht University Medical Center as the lead sponsor. The portfolio currently includes 45 recruiting studies, 11 active non-recruiting studies, and 427 completed studies. 28 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Cumulative planned enrollment across all listed trials is 188,983 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
672
Total Trials
45
Recruiting
11
Other Active
427
Completed
28
Terminated / Withdrawn
188,983
Total Enrollment
Termination reasons: Other71% · Recruitment21% · Efficacy4% · Funding4%
Recent Terminations
- NCT06077734 Stopped Feb 2026Atrophy, Muscle"This study was terminated prior to its planned completion due to unexpected low participant inclusion."
- Deep Sedation"Due to changes in logistics (indications Rf and attendance PFA), it has not been feasible to include the required number of participants in this study"
- NCT04794985 Stopped Aug 2024Covid19"With included subjects (n=140) we have sufficient power to answer the primary research question."
- Functional Dyspepsia"The inclusion of participants went more difficult than initially thought. Preliminary analysis showed that the difference between the groups was great enough to draw conclusions from it, so the trial is terminated prematurely."
- NCT06412744 Stopped May 2024Healthy"Difficulties finding participants"
- Overweight and Obesity"Recruitment was dependent on finding participants that had to receive an initial COVID-19 vaccination and we were unable to find new participants anymore."
- Childhood Obesity"Inclusion rate not reached and due to the COVID-19 pandemic not enough follow up measurements of the included participants."
- Cerebral Blood Flow"Not possible due to COVID-19"
- Insulin Sensitivity"Due to covid-19 pandemic"
- Pulmonary Disease"Interim analysis showed primary outcome was not going to be achieved."
Active Trials (11 total)
- NCT07454161
- NCT07547176
- NCT07395973
- NCT06700187
- NCT07256340
- NCT02266615
- NCT03019471
- Fuchs' Endothelial Dystrophy PHASE4NCT05716945
- NCT04745195
- NCT05463666
- Breast Cancer PHASE2NCT06335069
- NCT06746805
- NCT07177781
- NCT07049224
- NCT06330350
- Actinic Keratoses PHASE4NCT06499415
- NCT06676345
- NCT06007560
- NCT05463757
- NCT05976048